HIV expenditure on prevention and treatment in Indonesia

Indonesia: HIV expenditure on prevention and treatment was 156.88 million constant 2019 US$ in 2022. β–² Rising

Latest (2022)
156.88 million constant 2019 US$
Change on year
up 2.4%
World rank
19th
of 144 countries
All-time high
158.36 million constant 2019 US$
in 2019
All-time low
0 constant 2019 US$
in 2016
Years of data
15
2006–2022

HIV expenditure on prevention and treatment in Indonesia, 2006–2022

050.0M100.0M150.0M2006201420222006: 56.6M constant 2019 US$2007: 58.7M constant 2019 US$2008: 49.6M constant 2019 US$2009: 60.3M constant 2019 US$2010: 68.8M constant 2019 US$2011: 72.5M constant 2019 US$2012: 87.0M constant 2019 US$2015: 114.6M constant 2019 US$2016: 0 constant 2019 US$2017: 152.0M constant 2019 US$2018: 119.1M constant 2019 US$2019: 158.4M constant 2019 US$2020: 157.7M constant 2019 US$2021: 153.2M constant 2019 US$2022: 156.9M constant 2019 US$

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in constant 2019 US$.

Analysis

In 2022, hiv expenditure on prevention and treatment in Indonesia stood at 156.88 million constant 2019 US$.

That represents a change of up 2.4% on the previous year and up 80.3% over ten years.

Over the whole period, hiv expenditure on prevention and treatment in Indonesia peaked at 158.36 million constant 2019 US$ in 2019 and was at its lowest, 0 constant 2019 US$, in 2016.

That places Indonesia 19th out of 144 countries with data for 2022, putting it in the top quarter.

The long-run direction has been consistently rising across the 15 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
2000s 56.27 million constant 2019 US$ 49.56 million constant 2019 US$ 60.29 million constant 2019 US$ 4
2010s 96.55 million constant 2019 US$ 0 constant 2019 US$ 158.36 million constant 2019 US$ 8
2020s 155.94 million constant 2019 US$ 153.20 million constant 2019 US$ 157.73 million constant 2019 US$ 3

Countries ranked near Indonesia

  1. 16 Colombia 203.61 million constant 2019 US$ compare
  2. 17 Chile 202.10 million constant 2019 US$ compare
  3. 18 Ethiopia 173.27 million constant 2019 US$ compare
  4. 20 Namibia 146.54 million constant 2019 US$ compare
  5. 21 Rwanda 144.78 million constant 2019 US$ compare
  6. 22 Ghana 128.08 million constant 2019 US$ compare

See the full ranking of 144 places β†’

More health data for Indonesia

All data for Indonesia β†’

Frequently asked questions

What is hiv expenditure on prevention and treatment in Indonesia?
Hiv expenditure on prevention and treatment in Indonesia was 156.88 million constant 2019 US$ in 2022, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest hiv expenditure on prevention and treatment recorded in Indonesia?
The highest recorded value was 158.36 million constant 2019 US$ in 2019.
What is the lowest hiv expenditure on prevention and treatment recorded in Indonesia?
The lowest recorded value was 0 constant 2019 US$ in 2016.
How does Indonesia rank for hiv expenditure on prevention and treatment?
Indonesia ranks 19th out of 144 countries with data for 2022.
Is hiv expenditure on prevention and treatment rising or falling in Indonesia?
Over the last ten years it is up 80.3%. The long-run trend across the full record is rising.
Where does this Indonesia data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of HIV expenditure on prevention and treatment. Statizoid updates them automatically from the source API.

Download this data

CSV Β· JSON β€” 15 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
HIV expenditure on prevention and treatment
Unit
constant 2019 US$
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
144 places, 1,552 data points, 2002–2024
Last refreshed

Total in-country spending on HIV programs and services.